© F e r r a t a S t o r t i F o u n d a t i o n . logical role in a range of hematologic diseases, such as inherited dyserythropoiesis, sideroblastic anemias and low-grade myelodysplastic symdromes. 8, 12 In addition, transcriptome, epigenetic and proteomic studies in stem cell systems have indicated that specific metabolic/mitochondrial properties are essential for regulating the balance between self-renewal and differentiation. 13, 14 Although recent work has begun to shed light on the mitochondrial response during murine stem cell differentiation, 7, 10, 15, 16 how and to what extent the mitochondrial mass/function contributes to human hematopoietic stem and progenitor function remains poorly understood. Here, we found that mitochondrial mass correlates strongly with mitochondrial membrane potential (ΔΨm 
Introduction
Human hematopoietic stem cells (HSC) and hematopoietic progenitor cells (HPC) are almost exclusively enriched in the CD34 + fraction, which represents a rare cell subset (<1%) in cord blood, bone marrow and mobilized peripheral blood. 1, 2 In the setting of clinical transplantation, the dose of total CD34 + cells infused per kilogram of patient's bodyweight is used as a predictor of short-term hematopoietic recovery and establishment of long-term engraftment. 1, 3, 4 Although distinct surface markers (CD38, CD90, CD45RA, CD133, etc.) 5 have been experimentally used to distinguish between HSC or HPC, bona fide segregation of HSC and HPC relies on in vitro and in vivo functional assays.
It has been extensively demonstrated that the CD34 + fraction is phenotypically and functionally heterogeneous. Experimentally, only 1:10 to 1:4 of CD34 + or CD34 + CD38 -cells display clonogenic potential. Clinically, different outcomes/hematopoietic recovery are reported in patients with identical underlying disease who undergo hematopoietic stem/progenitor cell (HSPC) transplantation with equal doses of CD34 + cells after receiving identical chemotherapy treatment. It can, therefore, be speculated that genetically identical CD34
+ cells within the graft may exhibit cell-to-cell variations not only in the amount of individual gene products but also in metabolic homeostasis/mitochondrial status, resulting in phenotypic and functional diversity. 6 The metabolic status of HSC and HPC becomes crucial during clinical HSPC transplantation since the efficiency of donor-derived HSC/HPC to engraft, survive, home, proliferate and differentiate into multiple lineages in a chemotherapy-induced aplastic patient is markedly influenced by their hypoxic niche, demanding a significant metabolic adaptation to survive and promote rapid and stable hematopoietic reconstitution in chemotherapyinduced aplastic microenvironments. 7, 8 As in other tissues, mitochondria play key roles in HSC/HPC and have recently come under increased scrutiny because compelling evidence has revealed their role in numerous cellular processes, beyond ATP production and apoptosis regulation, and they have recently even been suggested to act as cell-fate or lineage determinants. [9] [10] [11] In fact, deregulation of mitochondrial function plays a pathophysio- October 11, 2012 . Manuscript accepted on January 9, 2013 . Correspondence: pablo.menendez@genyo.es
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The homeostasis of the hematopoietic stem/progenitor cell pool relies on a fine-tuned balance between selfrenewal, differentiation and proliferation. Recent studies have proposed that mitochondria regulate these processes. Although recent work has contributed to understanding the role of mitochondria during stem cell differentiation, it remains unclear whether the mitochondrial content/function affects human hematopoietic stem versus progenitor function. We found that mitochondrial mass correlates strongly with mitochondrial membrane potential in CD34
+ hematopoietic stem/progenitor cells. 8, 12 In addition, transcriptome, epigenetic and proteomic studies in stem cell systems have indicated that specific metabolic/mitochondrial properties are essential for regulating the balance between self-renewal and differentiation. 13, 14 Although recent work has begun to shed light on the mitochondrial response during murine stem cell differentiation, 7, 10, 15, 16 
Design and Methods

Cord blood collection and CD34 + cell isolation and culture
Fresh umbilical cord blood units from healthy neonates were obtained from local hospitals following approval from our local Ethics and Biohazard Board Committee. The cord blood samples were pooled to reduce variability among individual units. Mononuclear cells were isolated using Ficoll-Hypaque and after lysing the red cells (Cytognos, Salamanca, Spain), CD34 + cells were purified by magnetic bead separation using the human CD34 MicroBead kit and the AutoMACS Pro separator (Miltenyi Biotec) as instructed by the manufacturer. [17] [18] [19] The purity of the CD34 + fraction was assessed by flow cytometry using an anti-CD34-PE antibody (Miltenyi Biotec), and only CD34 + fractions showing purity higher than 90% were used. [17] [18] [19] The CD34 -fraction was irradiated (15 Gy) and used as accessory cells for co-transplantation with CD34 + cells. 
MitoTracker staining and cell sorting
Measurements of ATP and reactive oxygen species
ATP levels were measured using a Cell-Titer-Glo ® Luminescent Cell Viability Assay (Promega) according to the manufacturer's guidelines. Briefly, equal numbers of cells (5x10 4 /100 mL) were seeded in a 96-well plate and 100 mL of the reaction reagent were added to each well. After 10 min of shaking, the luminescence signal was detected using the GloMax ® -Multi Detection System (Promega) and compared against the ATP Standard Curve using ATP disodium salt (Promega). 6 Reactive oxygen species were measured using the mitochondrial superoxide indicator MitoSOX Red, as previously described. 
The polymerase chain reaction conditions were 50ºC for 2 min followed by 90ºC for 10 min and 40 cycles of 95ºC for 15 s and 60ºC for 60 s. 15 The expression of each gene was analyzed in three independent experiments performed in triplicate. + cells were fixed in 70% icecold ethanol and stored at -20°C. Subsequently, cells were washed with ice-cold phosphate-buffered saline and suspended in propidium iodide buffer containing 5 mg of propidium iodide and 100 mg/mL of RNAase. Cell cycle distribution discriminating between quiescent cells (G0/G1) and cycling cells (S/G2/M phase) was analyzed on a FACSCanto-II cytometer using FACSDiva and ModFit software (BD Bioscience). 21 The apoptotic status of Mito High and Mito Low CD34 + cells was assessed using the annexin-V apoptosis detection kit (BD Biosciences) according to the manufacturer's instructions. 21 Briefly, cells were harvested and washed twice with phosphate-buffered saline before staining with annexin V-phycoerythrin and 7-amino actinomycin D. Apoptotic cells were detected by gating the annexin V-positive fraction. 
In vitro
Colony-forming unit assay
Primary human clonogenic progenitor assays (n=6) were performed by plating 1000 sorted CD34 + cells into methylcellulose H4434 (Stem Cell Technologies) containing the human growth factors stem cell factor (50 ng/mL), granulocyte-macrophage colony-stimulating factor (10 ng/mL), interleukin-3 (10 ng/mL) and erythropoietin (3 U/mL). Colonies were counted and scored on day 14 of the colony-forming unit (CFU) assay using standard morphological criteria. 21 For secondary replating, all the CFU colonies from the primary methylcellulose culture were harvested, and a single-cell suspension was achieved, washed in Iscove's modified Dulbecco's medium and replated in the secondary CFU assay. . Mice (n=22) at 8 to 12 weeks of age were sublethally irradiated (2.5 Gy) for 6 to 12 h before transplantation. Mice were anesthetized by isoflurane inhalation, and intrabone marrow transplantation was performed as described in detail elsewhere. 21 irradiated accessory cells were transplanted in a volume of 30 mL. For pain relief, 0.1 mg/kg buprenorphine and 5 mg/kg carprofen were administered immediately after transplantation and 24 h after. [21] [22] [23] Mice were killed 7 weeks after transplantation. Cells from the bone marrow (injected tibia and from the contralateral tibia and femur), spleen, liver and peripheral blood were stained with anti-hHLA-ABC-FITC and anti-hCD45-APC-Cy7
(BD Biosciences) to analyze human chimerism by flow cytometry. All engrafted mice were assessed for multilineage analysis using antihCD33-PE for myeloid cells, anti-hCD19-APC for B cells, and antihCD34-PE-Cy7 for immature hematopoietic cells (BD Biosciences).
21,22,24
Statistical analysis
Data are expressed as mean ± SD. Statistical comparisons were performed using a paired Student's t test. Differences were considered statistically significant when the P value was <0.05.
Results
FACS sorting of CD34 + cells based on mitochondrial mass
We first analyzed by confocal cytometry the mitochondrial membrane potential (ΔΨm) and the mitochondrial mass using MitoTracker Red (CMXRos) and MitoTracker Green, respectively. A strong correlation was observed between mitochondrial mass and function (ΔΨm) in cord blood-derived CD34 + cells; the greater the mitochondrial content, the higher the ΔΨm ( Figure 1A) . Accordingly, CD34 + cells were FACS-sorted based on mitochondrial mass (MitoTracker Green) into CD34 + Mito High and CD34 + Mito Low ( Figure 1B ). Sorted CD34 + Mito High contain 2-fold higher ATP levels ( Figure 1C ) and also express the mitochondrial-specific genes ND1 and COX2 at a level 2-fold higher than that of CD34 + Mito Low ( Figure 1D ), confirming that CD34 + Mito High cells have more expression of the mitochondrial-specific genes ND1 and COX2, and produce more ATP.
Hematopoietic stem versus progenitor cell characteristics of metabolically sorted cells
We next tested whether isolation of cord blood-derived CD34 + cells based solely on their mitochondrial mass enriches for stem and/or progenitor cell function. We utilized in vitro clonogenic CFU assays as a read-out for HPC function, and bone marrow xenotransplantation assays into NSG mice as an in vivo read-out for SCID-repopulating HSC function. Figure  2A) . Scoring of the CFU revealed no differences in the CFU types (granulocyte-, macrophage-, granulocytemacrophage-, erythroid-and mix-) obtained from CD34 . Equal numbers of cells were transplanted into tibiae and mice were sacrificed 7 weeks later for chimerism analysis in multiple hematopoietic organs. Human chimerism was determined by flow cytometry using anti-CD45 and anti-HLA-ABC ( Figure  2B ). All engrafted mice were assessed for multilineage reconstitution using anti-CD19 (B cells), anti-CD33 (myeloid cells) and anti-CD34 (immature cells) ( Figure 2B ). The level of engraftment was higher in the mice transplanted with CD34 + Mito Low than in those transplanted with CD34
+ Mito High regardless of the tissue analyzed, being more significant in the injected bone marrow (79±18% versus 59±17%; P<0.05; Figure 2C, Figure 3B ). However, coinciding with the complete differ-© F e r r a t a S t o r t i F o u n d a t i o n . Figure 3C,D) , explaining the robust increased cell expansion of differentiated CD34 -Mito Low cultures as compared to differentiated CD34 -Mito High cultures ( Figure 3B ). Finally, the complete differentiation of CD34 + Mito Low cultures by day 15 of liquid culture coupled with their robust expansion from day 15 onwards (Figure 3A ,B) was accompanied by a mitochondrial adaptation, as demonstrated by a significant increase in energy (ATP) production ( Figure  3E ) and expression of the mitochondrial genes ND1 and COX2 ( Figure 3F ). This suggests that a mitochondrial response underlies the high proliferative activity of the CD34 + Mito Low -differentiated derivatives.
Discussion
Mitochondria are multi-functional organelles that play a vital role in the cell, providing most of the cellular energy and regulating Ca 2+ homeostasis, cell death, and differentiation; furthermore, they have recently been suggested to act as cell-fate or lineage determinants. [9] [10] [11] Hematopoietic tissue homeostasis relies on a finely tuned balance between very dynamic intrinsically and extrinsically regulated processes of self-renewal, differentiation and proliferation. Based on recent transcriptomic, epigenomic and proteomic studies, it has been proposed that the cellular metabolism regulates these processes in different stem cell systems. 14 The metabolic status of human HSC/HPC becomes crucial during clinical HSPC transplantation since the efficiency of donor-derived HSC/HPC to engraft, survive, home, proliferate and differentiate in chemotherapyinduced aplastic patients demands a significant metabolic adaptation to survive and promote rapid and stable hematopoietic reconstitution in chemotherapy-induced aplastic microenvironments. 7, 8 Furthermore, deregulation of mitochondrial functions plays a pathophysiological role in several hematologic diseases. 8, 12 Although recent work has begun to shed light on the mitochondrial response during stem cell differentiation, 7, 10, 15, 16 Low fraction displayed significantly higher in vivo reconstitution potential upon inoculation in NSG mice whereas the CD34 + Mito High fraction was more enriched in progenitor function with higher in vitro clonogenic capacity. This is in line with the "dogma" that stem cells are usually quiescent and contain low numbers of mitochondria whereas progenitors are more proliferative and contain higher numbers of mitochondria. 9, 10 The vast majority of CD34 + cells co-express the activation surface marker CD38 which is associated with HPC whereas a very small proportion of CD34 + cells lack CD38 expression and are considered to be enriched in HSC. 5, 23, 25 Accordingly, the proportion of CD34 +
CD38
-primitive cells was 6-fold higher in the CD34 + Mito Low than in the CD34 + Mito High fraction, supporting the concept that the CD34 + Mito Low fraction is enriched in repopulating HSC function, and also explaining, at least in part, the lower progenitor function of CD34 + Mito Low cells. Our data confirm previous findings in mice showing that the Mito Low cellular fraction of murine bone marrow is highly enriched in repopulating HSC, partially due to the enrichment of long-term HSC in this Mito Low fraction. 16 Furthermore, Simsek et al. 16 recently reported that murine long-term HSC are highly enriched in Meis1, a HSC-associated transcriptional factor required for definitive hematopoiesis, and in HIF-1α, a master regulator of glycolysis and mitochondrial respiration, including a metabolic shift toward anaerobic glycolysis. In line with this study, the expression of both HIF-1α and Meis1 was found to be robustly up-regulated in CD34 + Mito Low cells as compared to in CD34 + Mito High cells, confirming that these factors are robustly expressed in the CD34 cell fraction enriched in repopulating stem cell function. Interestingly, mitochondrial content enriches for either HSC or HPC but it does not seem to act as a determinant in progenitor/lineage com-
D. Romero-Moya et al.
1026
haematologica | 2013; 98(7) Low fraction because efficient in vivo hematopoietic reconstitution relies on a finely tuned balance between low proliferative/self-renewing CD34 + HSC and rapidly amplifying progenitors, many of which are far lineage-committed and lack CD34 expression.
Mitochondrial biogenesis during the differentiation of embryonic stem cells has recently been studied. 11, 27 Undifferentiated embryonic stem cells have a low mitochondrial content and low levels of ATP. Upon differentiation the mitochondrial content increases and mitochondrial biogenesis is activated to promote the synthesis of increased levels of ATP which seem to be required for the homeostasis of the differentiated cells. 28 genes ND1 and COX2. This suggests that HSPC differentiation and proliferation of rapidly amplifying lineagecommitted CD34 -cells are processes demanding up-regulation of mitochondrial content and biogenesis, and these properties seem to be conserved among embryonic stem cells and HSC/HPC.
Increased bioenergetics and mitochondrial activity come at an increased risk of oxidative damage, primarily in the form of reactive oxygen species (ROS) which are mainly generated by the mitochondria. 10, 31 Various recent studies in mice have provided evidence for a link between intracellular ROS levels and preservation of stem cell function, with increased levels of ROS being associated with reduced repopulating stem cell activity. 32, 33 Stem cells have strategies to lessen the negative impact of ROS such as lowering the numbers of mitochondria and ATP generation by promoting glycolysis over oxidative phosphorylation. 29, 34 In this study, human CD34 + Mito Low cells which were shown to be more enriched in HSC function displayed significantly lower levels of ROS than CD34 +
Mito
High cells (Online Supplementary Figure S1A ) which are more enriched in HPC function, suggesting that HSC function may be enriched in the CD34 + Mito Low fraction as a strategy to lessen the negative impact of ROS, which can induce cell damage/death. Finally, during mitosis mitochondria may be segregated to daughter cells either symmetrically or asymmetrically. Asymmetric cellular distribution of mitochondria is a dynamic process which has been observed in some species and may play a role in cellfate determination, differentiation and self-renewal. 11, 27, [35] [36] [37] Whether symmetric or asymmetric mitochondrial segregation occurs in human CD34 + cells is unknown. It would be worth studying in future work whether asymmetric mitochondrial segregation could be an underlying mechanism explaining why phenotypically identical CD34
+ cells may exhibit cell-to-cell variations in mitochondrial content resulting in functional diversity. 
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